Cargando…

mRNA-based vs viral vector-based COVID-19 vaccines

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435127/ http://dx.doi.org/10.1007/s40278-021-01937-y

Ejemplares similares

Younger males at greatest risk of myocarditis after mRNA-based COVID-19 vaccination
Publicado: (2022)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

Safety of mRNA COVID-19 vaccines during pregnancy
Publicado: (2022)

COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
Publicado: (2021)

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
Publicado: (2021)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Fourth-dose boosters with COVID-19 mRNA vaccines well tolerated
Publicado: (2022)

Cardiac risks higher after COVID-19 infection than mRNA vaccine
Publicado: (2022)

Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers
por: Klugar, Miloslav, et al.
Publicado: (2021)

Safety profile of mRNA vaccines during first 6 months of the US COVID-19 vaccination programme reviewed
Publicado: (2022)

An Update on mRNA-Based Viral Vaccines
por: Jeeva, Subbiah, et al.
Publicado: (2021)

Myocarditis following COVID-19 mRNA vaccination
por: Parmar, Kanak, et al.
Publicado: (2021)

New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA
por: Rezaei, Marzieh, et al.
Publicado: (2022)

European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events
por: di Mauro, Gabriella, et al.
Publicado: (2022)

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis
por: John, Binu V., et al.
Publicado: (2022)

Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy
por: Salerno, Laura, et al.
Publicado: (2021)

mRNA and Viral Vector COVID-19 Vaccines Do Not Affect Male Fertility: A Prospective Study
por: Massarotti, Claudia, et al.
Publicado: (2022)

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers
por: Spitaleri, G., et al.
Publicado: (2023)

Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
por: Massarweh, Amir, et al.
Publicado: (2022)

Retinal Vein Occlusion Amongst People Vaccinated by mRNA- and Viral Vector- COVID-19 Vaccines: A Systematic Review
por: Rachman, Maria Jessica, et al.
Publicado: (2023)

Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis
por: John, Binu, et al.
Publicado: (2022)

Safety of COVID-19 mRNA vaccination in children with chronic urticaria
por: Zhu, Catherine K., et al.
Publicado: (2023)

Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2022)

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination
por: Robinson, Lacey B., et al.
Publicado: (2021)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
por: Chavda, Vivek P., et al.
Publicado: (2023)

Panuveitis following mRNA-based COVID-19 vaccine
por: Bouayad, A., et al.
Publicado: (2023)

COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma
por: Prieto, Peter A, et al.
Publicado: (2021)

Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
por: Alenazy, Leila A., et al.
Publicado: (2022)

Durability of immune responses to mRNA booster vaccination against COVID-19
por: Arunachalam, Prabhu S., et al.
Publicado: (2023)

Transcription Expression and Clinical Significance of Dishevelled-3 mRNA and δ-Catenin mRNA in Pleural Effusions from Patients with Lung Cancer
por: Li, Xiao-Yan, et al.
Publicado: (2012)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
por: Sølund, Christina, et al.
Publicado: (2022)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination
por: Vered, Livneh, et al.
Publicado: (2022)

Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
por: Nace, David A., et al.
Publicado: (2021)

Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19
por: Juárez Guerrero, Alba, et al.
Publicado: (2021)

mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase
por: Koo, Grace, et al.
Publicado: (2022)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e5q8bqr38enlro1d21uua47h3d